What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New.

Slides:



Advertisements
Similar presentations
XVII CDAP Meeting with Judges and Prosecutors on Overcrowding in Prison Rome Mauro Palma Vice- Chair European Council for Penological Co-operation Council.
Advertisements

A call for prioritizing health and harm reduction in reforming drug policies Drug policy special session AIDS 2014 Melbourne July Dr Alex.
The development of an Australian drug policy index Assoc Prof Alison Ritter Director, Drug Policy Modelling Program (DPMP) University of New South Wales.
João Goulão, MD Portuguese National Drugs Coordinator President, Institute on Drugs and Drug Addiction “Leaders Against Criminalization at AIDS 2010” Vienna,
EU responses to hate crimes and support to the victims Linda Maria Ravo DG Justice – European Commission Unit C1.
THE NEED FOR HARM REDUCTION THE SITUATION IN BULGARIA Bulgarian DU Activism Milena Naydenova – Hope-Sofia.
ARQ part II data management Training pack 4: Terminology.
Drug treatment in prisons: recent evidence Jessica Harris, RDS NOMS, Home Office Malcolm Ramsay, DSPD Programme, Home Office.
Decriminalization of Drugs in Portugal: Lessons for Public Health Kellen Russoniello, JD, MPH Health Policy Fellow, ACLU of San Diego & Imperial Counties.
Community Paralegals Developing Peer Legal Support for People Who Use Drugs in Indonesia Bridging the Gaps Indonesian Drug Users Network (PKNI)
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
The deterrent effects of drug detection dogs on drug use in NSW, Australia Caitlin Hughes,¹ Don Weatherburn², Robert MacCoun 3 ¹ National Drug and Alcohol.
Treatment of drug addiction in prisons
Canada’s Drug Strategy. 2 Purpose Provide an overview of Canada’s renewed National Drug Strategy  Historical context  Impetus for change  Renewed National.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
Encuentro de Líderes Latinoamericanos con la Federación Mundial Contra Las Drogas MIÉRCOLES 3 DE DICIEMBRE DE 2014, BUENOS AIRES Sven-Olov Carlsson, International.
Harm Reduction.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Polydrug use challenges – European experience International Conference: New trends in drug use: facts and solutions, Parliament of the Republic of Vilnius.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Security in the Western Hemisphere Illicit Narcotics.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Theodore M. Hammett, Ph.D. Sofia Kennedy, M.P.H. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS NIH-Bethesda, MD May 9, 2007 HIV/AIDS.
Peter Sarosi Hungarian Civil Liberties Union (HCLU) Dialogoue on Drug Policy 8 June, European and Hungarian drug policies: based on evidence?
Drug Policy: Prohibition, Decriminalization, Legalization.
Twinning Project Implementation of Strategy for Fight Against Drugs in Serbia Kick off and Assessment November 2012 Belgrade.
Systematic Review of the Effectiveness of Alcohol Treatments in Offender Populations Amanda Roberts.
Australia’s Drug Policy Greg Denham Nossal Institute for Global Health.
Ernesto U. Savona Professor of Criminology at Università Cattolica, Milan and Director of TRANSCRIME CRIME AND DEVELOPMENT A Complex.
The case for developing more effective approaches to alcohol and drug problems Probation and Community Corrections Officers Conference Dr Alex Wodak AM.
The international use and misuse of the Portuguese (decriminalisation) example Dr Caitlin Hughes ISSDP/ESC meeting on Portuguese drug policy, Porto, 2.
Australian alternatives to arrest and imprisonment for drug and drug-related offenders: Assessing program and system outcomes Dr Caitlin Hughes and Dr.
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
Prison Reforms - UNODC perspective Dr. Jayadev Sarangi, Prison Expert UNODC ROSA APCCA,2008 Langkawi, Malaysia, 24th November 2008.
EU model – evidence based Out of 100% of people who tried drugs, only 10% get to chronicle stage Out of 100% of people who tried drugs, only 10% get to.
Global Trends in Decriminalisation: A Quiet Revolution Jamie Bridge International Drug Policy Consortium (IDPC) on behalf of Release Thursday 14th March.
A tale of two drug policies: Portugal and Sweden Alex Stevens, PhD Professor in Criminal Justice.
Harm Reduction International
Maryland’s “Good Samaritan” Law Annotated Code of Maryland, Criminal Procedure §1-210 Effective October 1, 2015 September
The UN General Assembly Special Session on Drugs & the shifting global drug policy landscape Ann Fordham Executive Director 12 th November 2015 Citywide.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Decriminalisation and Regulation Pragmatic responses to drug use & supply Niamh Eastwood Release.
What is the situation in Portugal 14 years after the reformof the drug policy Rita Faria Jorge Quintas School of Criminology – Faculty of Law of the University.
MODULE 2 Effective drug policy What needs to change?
HIV Prevention, Treatment and Care in Prisons and other Closed Settings Ehab Salah Prisons and HIV Advisor UNODC, Vienna ICASA 2015 Harare, Zimbabwe 2.
1 BRIEFING TO THE PARLIAMENTARY PORTFOLIO COMMITTEE ON SOCIAL DEVELOPMENT: ROLE OF THE DEPARTMENT OF JUSTICE AND CONSTITUTIONAL DEVELOPMENT ON THE PREVENTION.
Social rehabilitation and reintegration of drug addicts in community – experience from EU Dr. Josef Radimecký, Ph.D., MSc. UN International Day against.
FIDUCIA New European Crimes and Trust-based Policy OVERCRIMINALIZATION AND PRISON OVERCROWDING: RECENT FINDINGS FROM THE FIDUCIA PROJECT IN THE FIELD OF.
…Implications for Wales Josie Smith Programme Lead for Substance Misuse, Public Health Wales TOWARDS A HEALTH BASED APPROACH.
Cannabis use in the Americas Slides for presentation at NIDA International Forum.
Law Enforcement agencies and civil society organizations: critical partners in HIV services provision for people who use drugs Zhannat Kosmukhamedova,
‘Global trends in decriminalisation: A quiet revolution ’ 2.0 Niamh Eastwood Release 16 May 2016.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
‘The War on Drugs: Failures, Impacts, and Alternatives, and the Future of Public Health’ Niamh Eastwood Release 15 November 2014.
Cje Karolina Kremens, LL.M., Ph.D. Wojciech Jasiński, Ph.D. Department of Criminal Procedure Faculty of Law, Administration and Economics University of.
Briefing to Member States Information under embargo
João Goulão General-Director for Intervention on Addictive Behaviors and Dependencies National Coordinator on Drugs, Drug Addiction and the Harmful Use.
A comprehensive policy for alternatives to imprisonment: Decriminalization of drug use in Portugal and impact on Public Health Session: Alternatives to.
Treatment and Care of People with Drug Misuse Disorders in Contact with the CJS: Alternatives to Conviction or Punishment Tim McSweeney, Dept of Criminology.
Crime Prevention Legal Studies 3C.
COLLECTIVE IMPACT APPROACH TO ADDRESSING
Harm reduction: decriminalising drug use in Asia
Drug Prohibition Part 3 of 3 David Zokaites September 5, 2017
Decriminalisation Policy and the role of the CDT
Niamh Eastwood Executive Director Release
Beyond drug criminalisation: Why, what and how?
Presentation transcript:

What can we learn from the Portuguese decriminalization of illicit drugs? Dr Caitlin Hughes Drug Policy Modelling Program NDARC, The University of New South Wales Co-author: Professor Alex Stevens University of Kent ACT Legislative Assembly Thursday, 17 Nov 2011 DPMP is funded by the Colonial Foundation Trust

Decriminalisation vs legalisation? Decriminalisation: removal of sanctions under criminal law, with optional use of alternate sanctions Legalisation: complete removal of sanctions, making behaviour legal and applying no criminal or administrative penalty

Portugal pre reform Low prevalence of lifetime drug use e.g. In % of pop aged reported ever having used an illicit drug Increasing rates of problematic drug use, HIV, Hepatitis C Growing concern over the social exclusion and marginalization of drug users Perception that criminalization of drug use was worsening the problem

The Portuguese reform Aim: – 1. To remove drug users from the criminal justice system – 2. To discourage and/or treat drug use Law 30/2000: use, possession and acquisition of all illicit drugs, when in small quantities, deemed a public order offence Detected users sanctioned through Commissions for the Dissuasion of Drug Addiction (CDTs) which employ a panel of experts CDTs seek to: – Discuss pattern of drug use and motivations and circumstances of use – Refer dependent people to treatment – Provide alternate sanctions for non-dependent Introduced as part of a new national drug strategy that expanded treatment, harm reduction etc services

Key features of the Portuguese decriminalisation Applies to all illicit drugs (most other examples of decriminalisation apply to cannabis only) Legislative reform (not just practice based) Seeks to provide a therapeutic and social response (not just the removal of criminal sanctions) Employs drug law reform as a tool to ‘enable’ other drug policy levers: treatment, harm reduction, social inclusion, law enforcement etc

Proviso The lack of a ‘non-reform Portugal’ and the multiplicity of changes make it impossible to attribute any changes in drug use or related harm directly to the fact or form of the Portuguese decriminalization Yet, we can test the hypotheses aired at the time, that the reform would: 1.Incite interest in drug use 2.Increase drug related harms 3.Reduce the ability of the criminal justice system to function effectively

CDTs – numbers processed

CDT– rulings made

Did reform incite drug use?

Trends in any illicit drug use - general population (aged 15-64)

Trends in recent use – by age group

Trends in recent use – by drug type

Trends in school students - recent cannabis use (ESPAD data)

Did reform increase drug- related harms?

Trends in problematic drug users (per 1000 pop aged 15–64 years) – Portugal vs. Italy

Impacts on drug-induced deaths Drug-related deaths: Deaths that involve a positive post-mortem toxicological test for the presence of any illicit substance (regardless of whether or not the drug caused the death). Drug-induced deaths: Deaths that physicians determined according to International Classification of Disease protocols to be directly attributable to drug use.

Impacts on drug-related HIV and treatment provision No. users with HIV No. users with AIDS No. in drug treatment 23,65438,532

Did reform reduce the capacity of the criminal justice system to function effectively?

Portugal – Trends in CJS burden-1

Portugal – Trends in CJS burden-2

Trends in Spain

Impact on prisons and law enforcement ability Impacts on prisons Between 1999 and 2008 proportion of drug-related offenders in prison decreased from 44% to 21% Between 2001 and 2007 use of heroin within prison decreased from 27% to 13% Both findings have been very welcome, due to the historic overcrowding of Portuguese prisons. Impacts on law enforcement ability Law enforcement officials suggest they have been able to: refocus their attention on the upper end of the drug market; enhance their international collaborative efforts; and introduce more systematic investigative techniques. Supported by increased quantity of seizures post reform

Implications Ten years post reform there is evidence of: – Only small increases in recent drug use – Reductions in the prevalence of problematic drug use – Increased uptake of treatment – Reduction in drug-induced deaths and HIV – Reduced burden on criminal justice system, particularly prison Important to emphasise this is not only a consequence of the law reform But this indicates that even when conducted for all illicit drugs: – Decriminalising use, possession and acquisition will not inevitably lead to a rampant increase in illicit drug use – Nor does it appear to lead automatically to an increase in drug-related harms – It may even assist governments to reduce net harm to the general community

Thank You Contact details: Dr Caitlin Hughes P: E: For more information see: Hughes, C.E. & Stevens, A. (2010) What can we learn from the Portuguese decriminalization of illicit drugs? British Journal of Criminology, 50(6), Hughes, C.E. (2006) Overcoming obstacles to reform? Making and shaping drug policy in contemporary Portugal and Australia, PhD thesis, Department of Criminology, The University of Melbourne.